Medical Economics 95th Physician Report
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
This analysis indicates that quantitative interstitial abnormalities may indicate alterations in lung tissue processes that can result in short- and long-term consequences as far as…
Take this survey powered by surveymonkey.com. Create your own surveys for free.
AUA 2024, N-803 plus BCG, Non Muscle Invasive Bladder Cancer (NMIBC), BCG Refractory, QUILT 3032 trial, ANKTIVA, interleukin-15 superagonist (IL-15), BCG-unresponsive high-grade NMIBC.
AUA 2024, non-muscle invasive bladder cancer (NMIBC), trans urethral resection of bladder tumor (TURBT), HG T1 bladder cancer, Replacing ReTUR with Cystoscopy, HuNIRe trial, urine cytology,…
AUA 2024 efficacy of repeat BCG challenge in patients with “BCG unresponsive” non-muscle invasive bladder cancer (NMIBC), BCG-unresponsive NMIBC,
Taking this survey lets CNF and other patient advocacy organizations better understand the challenges you face as a caregiver, and lets us develop better resources…
Andrea Apolo joins Sam Chang in discussing the AMBASSADOR study, focusing on adjuvant pembrolizumab for muscle-invasive urothelial carcinoma. The study showed improved disease-free survival with…
AUA 2024 third interim analysis of the DARolutamide ObservationaL (DAROL) study, nonmetastatic castration-resistant prostate cancer (nmCRPC), DAROL study, darolutamide, phase 3 ARAMIS trial.
AUA 2024, muscle-invasive bladder cancer (MIBC), depression in muscle-invasive bladder cancer patients, neoadjuvant chemotherapy (NAC), Effects of Neoadjuvant Chemotherapy on Rates of Depression.
Technological advancements, evolving patient expectations, and global health challenges reshape how healthcare professionals deliver care.